ICD10 code of ROHHAD and ICD9 code

ROHHAD syndrome does not currently have a unique, dedicated ICD-10 or ICD-9 code, as it is classified under broader categories due to its rarity. Clinicians typically use codes for its constituent symptoms, such as E66.8 (other obesity) or G47.3 (sleep apnea), though it is recognized in medical literature under the Orphanet identifier ORPHA:79109.

Why does ROHHAD lack a specific ICD code?

ROHHAD (Rapid-onset Obesity with Hypothalamic dysfunction, Hypoventilation, and Autonomic Dysregulation) is an extremely rare condition, with fewer than 200 cases reported worldwide in medical literature. Because of this limited prevalence, the World Health Organization and national coding bodies have not assigned it a unique, standalone code. When billing or documenting care for ROHHAD, physicians must often report the individual clinical manifestations—such as hypothalamic obesity, central hypoventilation syndrome, and autonomic nervous system dysfunction—to accurately reflect the complexity of the patient’s health profile.

What are the primary clinical features of ROHHAD?

ROHHAD is a complex, life-altering condition that typically presents in early childhood, often between the ages of 1.5 and 4 years. The syndrome is characterized by a rapid and often extreme onset of weight gain, followed by a progression of systemic issues. Understanding the multisystem nature of ROHHAD is vital for early intervention and management, as the autonomic dysfunction can lead to significant cardiac and respiratory risks.

How is the diagnosis of ROHHAD established?

There is no single blood test or genetic marker that confirms ROHHAD. Diagnosis is currently clinical, based on the presence of the hallmark features for which the syndrome is named. Specialists often perform a rigorous exclusion process to rule out other endocrine, genetic, or neurological conditions. The following clinical criteria are essential for a ROHHAD diagnosis:

• Rapid-onset obesity: Significant, uncontrollable weight gain occurring after age 1.5.


• Hypothalamic dysfunction: Manifesting as hypernatremia, hypothyroidism, or growth hormone deficiency.


• Hypoventilation: Particularly during sleep, often requiring mechanical ventilation support.


• Autonomic Dysregulation: Symptoms such as temperature instability, impaired pupillary response, or gastrointestinal motility issues.


• Neural crest tumors: Monitoring for ganglioneuromas or ganglioneuroblastomas is a standard part of ROHHAD surveillance.

Is there support for families affected by ROHHAD?

Navigating a rare disease diagnosis like ROHHAD can feel isolating, but you are not alone. Currently, 24 people with ROHHAD have joined the DiseaseMaps.org community to share their experiences and offer peer support. Connecting with others who understand the unique challenges of managing hypothalamic dysfunction and chronic respiratory support can provide both practical insights and emotional grounding for families.

Next steps

• Consult with a pediatric endocrinologist and a pulmonologist who have experience with complex autonomic disorders.


• Establish a surveillance schedule for neural crest tumors, which is critical for all children diagnosed with ROHHAD.


• Join the DiseaseMaps.org community to connect with other families and stay informed about the latest research and support resources.


• Discuss with your medical team the possibility of participating in international registries to help researchers better understand the underlying causes of this condition.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: ORPHA79109 (ROHHAD syndrome)


• NIH Genetic and Rare Diseases Information Center (GARD)


• OMIM (Online Mendelian Inheritance in Man): Entry #616260


• ROHHAD Association (International patient advocacy and research foundation)